Genworth Financial, Inc. (NYSE: GNW) is a Financial Services company in the Insurance - Diversified industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
9.77
+0.08+0.77%
News
Up 0.8% — Genworth Financial Q2 Earnings Call Highlights (marketbeat.com).
Medium confidence
TA
Loading chart...
Snapshot
| Index | - | P/E | 17.78 | EPS (ttm) | 0.55 | Insider Own | 3.36% | Shs Outstand | 383.01M | Perf Week | -1.42% |
| Market Cap | 3.71B | Forward P/E | 8.61 | EPS next Y | 1.13 | Insider Trans | -1.17% | Shs Float | 373.59M | Perf Month | 5.10% |
| Enterprise Value | 1.73B | PEG | 0.89 | EPS next Q | - | Inst Own | - | Short Float | 2.32% | Perf Quarter | 6.02% |
| Income | 213.03M | P/S | 0.53 | EPS this Y | 105.66% | Inst Trans | - | Short Ratio | 3.12 | Perf Half Y | 8.27% |
| Sales | 6.99B | P/B | 0.42 | EPS next Y | 3.21% | ROA | 0.24% | Short Interest | 8.67M | Perf YTD | 7.31% |
| Book/sh | - | P/C | 7.09 | EPS next 5Y | 3.21% | ROE | 2.42% | 52W High | 10.28 -5.00% | Perf Year | 18.03% |
| Cash/sh | - | P/FCF | 7.12 | EPS past 3/5Y | -23.16% -18.37% | ROIC | 0.67% | 52W Low | 7.90 23.60% | Perf 3Y | 60.96% |
| Dividend Est. | - | EV/EBITDA | 3.08 | Sales past 3/5Y | -4.87% -4.96% | Gross Margin | 40.63% | Volatility | 2.27% 2.31% | Perf 5Y | 190.12% |
| Dividend TTM | - | EV/Sales | 0.25 | EPS Y/Y TTM | -22.06% | Oper. Margin | 5.75% | ATR (14) | 0.21 | Perf 10Y | 243.62% |
| Dividend Ex-Date | Oct 08, 2008 | Quick Ratio | 0.00 | Sales Y/Y TTM | -4.58% | Profit Margin | 3.03% | RSI (14) | 49.02 | Recom | 2.88 |
| Dividend Gr. 3/5Y | 14.00% - | Current Ratio | 0.00 | EPS Q/Q | 133.33% | SMA20 | -1.99% | Beta | 0.85 | Target Price | - |
| Payout | 0.00% | Debt/Eq | 0.00 | Sales Q/Q | -3.09% | SMA50 | 3.47% | Rel Volume | 1.01 | Prev Close | 9.69 |
| Employees | 3,100 | LT Debt/Eq | 0.15 | Earnings | Nov 04 | SMA200 | 9.66% | Avg Volume | 2.87M | Price | 9.77 |
| IPO Date | May 25, 2004 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 60.00% 3.13% | Net Debt/EBITDA | -3.54 | Volume | 2,885,688 | Change | 0.77% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jun-18-25 | Upgrade | Keefe, Bruyette & Woods | Market Perform → Outperform | |
| Nov-11-16 | Upgrade | Compass Point | Neutral → Buy | |
| Oct-05-16 | Downgrade | BTIG Research | Buy → Neutral | |
| Sep-19-16 | Downgrade | Compass Point | Buy → Neutral | |
| Nov-04-15 | Downgrade | UBS | Neutral → Sell | |
| Aug-06-15 | Downgrade | Raymond James | Strong Buy → Outperform | |
| Aug-05-15 | Upgrade | Macquarie | Underperform → Neutral | |
| May-28-15 | Upgrade | Morgan Stanley | Underweight → Equal Weight | |
| May-05-15 | Downgrade | Morgan Stanley | Equal Weight → Underweight | |
| Apr-30-15 | Downgrade | Compass Point | Buy → Neutral |
Latest News
Aug-08-26
Aug-06-26
10:41AM
Aug-05-26
Jul-30-26
Jul-30-2603:33AM
Jul-21-26
10:41AM
Jul-15-26
Jul-13-26
Jul-13-2609:16AM
Jul-09-26
Jul-07-26
Jul-07-2604:12PM
04:10PM
Jun-17-26
Company
Genworth Financial, Inc., together with its subsidiaries, provides mortgage and long-term care insurance products in the United States. It operates through two segments: Enact and Closed Block. The company offers primary mortgage, and mortgage insurance products, and contract underwriting services. It also provides long-term care insurance products that are intended to protect against the significant and escalating costs of long-term care services provided in the insured’s home, assisted living, and nursing facilities. In addition, the company offers protection and retirement income products, that includes traditional and non-traditional life insurance, such as term, universal and term universal life insurance, corporate-owned life insurance, and funding agreements; fixed annuities; and variable annuities. It distributes its products through sales force, sales representatives, and digital marketing programs. Genworth Financial, Inc. was founded in 1871 and is headquartered in Glen Allen, Virginia.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6,990 | 6,367 | 7,143 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 4,150 | 4,821 | 6,585 | — | — | — | — | — | — | |
| Gross Profit | 2,840 | 1,546 | 558 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 0 | 0 | 0 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 2,438 | 1,113 | -37 | — | — | — | — | — | — | |
| Operating Income | 402 | 433 | 595 | — | — | — | — | — | — | |
| Interest Expense | 104 | 105 | 115 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 104 | 105 | 115 | — | — | — | — | — | — | |
| Net Income Before Taxes | 402 | 433 | 595 | — | — | — | — | — | — | |
| Income Taxes | 70 | 84 | 158 | — | — | — | — | — | — | |
| Consolidated Net Income | 212 | 223 | 299 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 332 | 349 | 437 | — | — | — | — | — | — | |
| Net Income | 212 | 223 | 299 | — | — | — | — | — | — | |
| EPS (Recurring) | 0.54 | 0.55 | 0.69 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.54 | 0.55 | 0.69 | — | — | — | — | — | — | |
| EPS (Diluted) | 0.54 | 0.54 | 0.68 | — | — | — | — | — | — | |
| EBITDA | 561 | 631 | 840 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 18.08 | 16.72 | 10.28 | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.53 | 0.58 | 0.42 | — | — | — | — | — | — | |
| Gross Margin | 40.63 | 24.28 | 7.81 | — | — | — | — | — | — | |
| Operating Margin | 5.75 | 6.80 | 8.33 | — | — | — | — | — | — | |
| Net Margin | 3.03 | 3.50 | 4.19 | — | — | — | — | — | — | |
| Shares Outstanding | 381 | 409 | 434 | — | — | — | — | — | — | |
| Market Capitalization | 3,720 | 3,693 | 3,034 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Shah Samir B. | Pres. & CEO, CareScout | Jul 13 '26 | Option Exercise | 0.00 | 15,965 | 0 | 131,919 | Jul 14 |
| McInerney Thomas J | President and CEO; Director | May 22 '26 | Sale | 9.27 | 100,000 | 927,000 | 5,368,883 | May 27 |
| RESTREPO ROBERT P JR | Director | May 22 '26 | Sale | 9.12 | 50,000 | 456,055 | 92,655 | May 26 |
| Taylor Morris C. | EVP & CIO | May 21 '26 | Option Exercise | 0.00 | 21,521 | 0 | 21,521 | May 22 |
| Arland Jamala M. | Pres. & CEO, U.S. Life Ins. | Mar 02 '26 | Option Exercise | 0.00 | 24,959 | 0 | 112,914 | Mar 03 |
| McInerney Thomas J | President and CEO; Director | Mar 02 '26 | Option Exercise | 0.00 | 665,574 | 0 | 5,773,018 | Mar 03 |
| Upton Jerome T | EVP & Chief Financial Officer | Mar 02 '26 | Option Exercise | 0.00 | 83,196 | 0 | 596,943 | Mar 03 |
| Saltzgaber Kelly A | EVP & Chief Investment Officer | Mar 02 '26 | Option Exercise | 0.00 | 49,918 | 0 | 158,981 | Mar 03 |
| Karawan Gregory S. | EVP and General Counsel | Mar 02 '26 | Option Exercise | 0.00 | 49,918 | 0 | 405,635 | Mar 03 |
| Hodges Mark Blakeley | EVP and Chief Risk Officer | Mar 02 '26 | Option Exercise | 0.00 | 49,918 | 0 | 189,029 | Mar 03 |
| Hagerman Melissa | EVP and Chief HR Officer | Mar 02 '26 | Option Exercise | 0.00 | 49,918 | 0 | 229,761 | Mar 03 |
| Hagerman Melissa | EVP and Chief HR Officer | Feb 26 '26 | Option Exercise | 0.00 | 45,157 | 0 | 186,899 | Feb 27 |
| Upton Jerome T | EVP & Chief Financial Officer | Feb 26 '26 | Option Exercise | 0.00 | 80,937 | 0 | 524,162 | Feb 27 |
| Shah Samir B. | Pres. & CEO, CareScout Svcs. | Feb 26 '26 | Option Exercise | 0.00 | 80,937 | 0 | 111,712 | Feb 27 |
| Saltzgaber Kelly A | EVP & Chief Investment Officer | Feb 26 '26 | Option Exercise | 0.00 | 57,445 | 0 | 117,218 | Feb 27 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.